A technique which allows stem cells to be reprogrammed to produce any type of human cell in industrial quantities has been created by Cambridge company Bit.bio.
The technology could be used for patient therapies, studying rare diseases or discovering new medicines.
BBC Click’s Jen Copestake reports.
See more at Click’s website and @BBCClick
